{"id":"7e112bb0-b027-4268-a32e-24106887453f","kind":"institutions","code":"UB-I1531","name":"Guangyao Group","nameBasis":"transliterated","summary":"Guangzhou Pharmaceutical Holdings, GPHL, a large traditional Chinese medicine and pharmaceutical group investing strategically across the healthcare value chain.","description":"Guangzhou Pharmaceutical Holdings, GPHL, a large traditional Chinese medicine and pharmaceutical group investing strategically across the healthcare value chain.","country":null,"category":null,"originalName":"广药集团","eventDate":null,"website":null,"sourceUpdatedAt":"2026-10-15T10:56:24.838Z","englishUpdatedAt":"2026-10-15T21:41:18.601Z","reviewedAt":"2026-10-15T21:41:18.601Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"09cd2ec733297f69225b782fc2758eda1257cd1d9770fcb86c73e720f2a13bcf","companyId":null,"foundedYear":null,"logoUrl":null,"originalText":"广州医药集团（GPHL），大型中医药与医药产业集团，围绕医药健康产业链战略投资。","sources":[],"related":[{"id":"92ed57b6-55a9-470f-aec7-40ecc6950658","kind":"news","code":"92ed57b6-55a9-470f-aec7-40ecc6950658","name":"Baiyin Biotechnology completes equity financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"柏垠生物完成股权投资融资","eventDate":"2025-11-03T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-10T18:51:46.444Z","englishUpdatedAt":"2026-10-15T18:29:25.547Z","reviewedAt":"2026-10-15T18:29:25.547Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"6405f8e98fb4f858e023e16d4113559fcfbc8ef6a0513a7333a8d8b4695e88a1","companyId":"08f30ba8-7e91-40f9-a585-d269e673a470","foundedYear":null,"logoUrl":null,"path":"/news/92ed57b6-55a9-470f-aec7-40ecc6950658"},{"id":"d027e4a1-dd7b-4c40-bf79-9176feb90009","kind":"news","code":"d027e4a1-dd7b-4c40-bf79-9176feb90009","name":"Side Medical completes equity financing","nameBasis":"translated-title","summary":"","description":"","country":null,"category":null,"originalName":"思德医疗完成股权投资融资","eventDate":"2025-11-11T00:00:00.000Z","website":null,"sourceUpdatedAt":"2026-10-13T17:03:36.441Z","englishUpdatedAt":"2026-10-15T17:35:40.697Z","reviewedAt":"2026-10-15T17:35:40.697Z","snapshotAt":"2026-10-15T14:23:27.067Z","sourceHash":"e02ce710fdb167c61571be2c422e70fbeb68f79771e009604469f84b672f5b63","companyId":"6edcafc2-2d83-426f-b2bb-a8ab5b1f0de3","foundedYear":null,"logoUrl":null,"path":"/news/d027e4a1-dd7b-4c40-bf79-9176feb90009"}],"path":"/institutions/guangyao-group","displayName":"广药集团","displayNameLang":"zh","structured":{"city":null,"country":"China (mainland)","location":null,"role":null,"category":null,"company":null},"definition":"广药集团 is a corporate venture capital investor based in China (mainland) with 2 recorded investments in 2 companies.","summaryBasis":"translated","thin":false,"canonical":"https://uniquebase.ai/institutions/guangyao-group"}